Literature DB >> 22795596

Association between S21 substitution in the core protein of hepatitis B virus and fulminant hepatitis.

Jun Inoue1, Yoshiyuki Ueno, Kaori Kawamura, Takeshi Yamamoto, Yutaka Mano, Masahito Miura, Tomoo Kobayashi, Hirofumi Niitsuma, Yasuteru Kondo, Eiji Kakazu, Masashi Ninomiya, Osamu Kimura, Noriyuki Obara, Naoki Kawagishi, Yoshitaka Kinouchi, Tooru Shimosegawa.   

Abstract

BACKGROUND: The viral factors of hepatitis B virus (HBV), such as genotypes and mutations, were reported to affect the development of fulminant hepatitis B (FHB), but the mechanism is still unclear.
OBJECTIVES: To investigate HBV mutations associated with FHB, especially in the subgenotype B1/Bj HBV (HBV/B1), which are known to cause FHB frequently in Japan. STUDY
DESIGN: A total of 96 serum samples from acute self-limited hepatitis B (AHB) patients and 13 samples from FHB patients were used for full-genome/partial sequencing. A total of 107 chronic infection patients with HBV were also examined for the distribution of mutants.
RESULTS: In the analysis of full-genome sequences of HBV/B1 (FHB, n=11; non-FHB, n=35) including those from the databases, mutations at nt 1961 [T1961V (not T)] and nt 1962 [C1962D (not C)], which change S21 in the core protein, were found more frequently in FHB than in non-FHB (100% vs. 20%, 55% vs. 3%, respectively). When our FHB and AHB samples were compared, T1961V and C1962D were significantly more frequent in FHB than in AHB, both in the overall analysis (46% vs. 6%, 39% vs. 3%, respectively) and in HBV/B1 (100% vs. 29%, 100% vs. 14%, respectively). A newly developed PCR system detecting T1961V showed that HBV/B1 and low viral load were independent factors for the mutation among chronic infection patients.
CONCLUSIONS: T1961V/C1962D mutations were found frequently in FHB, especially in HBV/B1. The resulting S21 substitution in the core protein may play important roles in the development of FHB.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795596     DOI: 10.1016/j.jcv.2012.06.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy.

Authors:  Jun Inoue; Yasuteru Kondo; Yuta Wakui; Takayuki Kogure; Tatsuki Morosawa; Yasuyuki Fujisaka; Teruyuki Umetsu; Satoshi Takai; Takuya Nakamura; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2016-02-26

2.  Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.

Authors:  Takashi Hoshino; Hitoshi Takagi; Yuhei Suzuki; Atsushi Naganuma; Ken Sato; Satoru Kakizaki; Tsutomu Nishizawa; Hiroaki Okamoto; Masanobu Yamada
Journal:  Clin J Gastroenterol       Date:  2016-05-10

3.  Management of hepatitis B virus-related acute liver failure.

Authors:  Makoto Oketani; Hirofumi Uto; Akio Ido; Hirohito Tsubouchi
Journal:  Clin J Gastroenterol       Date:  2014-01-24

4.  Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants.

Authors:  Shan Gao; Shivali S Joshi; Carla Osiowy; Y Chen; Carla S Coffin; Z-P Duan
Journal:  Virol J       Date:  2017-10-24       Impact factor: 4.099

Review 5.  Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development.

Authors:  Thomas Mina; Samad Amini Bavil Olyaee; Frank Tacke; Piet Maes; Marc Van Ranst; Mahmoud Reza Pourkarim
Journal:  Hepat Mon       Date:  2015-06-23       Impact factor: 0.660

6.  Hepatitis E virus and fulminant hepatitis--a virus or host-specific pathology?

Authors:  Donald B Smith; Peter Simmonds
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.